CLOs on the Move

PetVivo

www.petvivo.com

 
PetVivo, Inc is an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices for pets, or pet therapeutics. PetVivo believes that it can leverage the investments in the human biomaterials and medical device industries to commercialize therapeutics to pets in a capital and time efficient way. PetVivo`s strategy is to in-license proprietary products from human medical device companies specifically for use in pets. PetVivo, Inc, Gel-Del Technologies, Inc. and CosmetaLife a Corporation are all wholly-owned subsidiaries of PetVivo Holdings, Inc.
  • Number of Employees: 100-250
  • Annual Revenue: $250-500 Million
  • www.petvivo.com
  • 5251 Edina Industrial Boulevard
    Minneapolis, MN USA 55439
  • Phone: 952.405.6216

Executives

Name Title Contact Details

Similar Companies

Beitler-Mc Kee Optical Co

Beitler-Mc Kee Optical Co is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Dthera

Dthera™ Sciences (OTCQB:DTHR) is the leading digital therapeutic company focusing on the elderly. The San Diego-based, publicly traded company is working to improve the lives of seniors and individuals suffering from neurodegenerative diseases, as well as those who care for them. It has two core products: ReminX™, a commercially available consumer health product for individuals suffering from social isolation and dementia; and DTHR-ALZ, and a development-stage product that has been granted Breakthrough Device designation by the FDA for the mitigation of the symptoms of agitation and depression associated with Alzheimer`s disease.

Bonutti Clinic

Bonutti Clinic is a Effingham, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Merlin Development Inc

Merlin Development Inc is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medpace

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 4,400 people across 40 countries.